Press release
Lawsuit filed for Investors who lost money with shares of aTyr Pharma, Inc. (NASDAQ: ATYR)
A lawsuit was filed on behalf of investors in aTyr Pharma, Inc. (NASDAQ: ATYR) shares over alleged securities laws violations.
Investors who purchased shares of aTyr Pharma, Inc. (NASDAQ: ATYR) have certain options and for certain investors are short and strict deadlines running. Deadline: December 8, 2025. NASDAQ: ATYR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
San Diego, CA based aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.
On September 15, 2025, aTyr announced topline results from its Phase 3 EFZO-FIT study, which "did not meet its primary endpoint of change from baseline in mean daily oral corticosteroid ("OCS") dose at week 48." Following this news, the price of the Company's stock declined.
Shares of aTyr Pharma, Inc. (NASDAQ: ATYR) declined from $7.29 per share on July 28, 2025, to as low as $0.682 per share on October 01, 2025.
The plaintiff alleges on behalf of purchasers of aTyr Pharma, Inc. (NASDAQ: ATYR) common shares between January 16, 2025 and September 12, 2025, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between January 16, 2025 and September 12, 2025, the defendants concealed material adverse facts concerning the efficacy of Efzofitimod, particularly, the drug's capability to allow a patient to completely taper their steroid u
Those who purchased shares of aTyr Pharma, Inc. (NASDAQ: ATYR) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lawsuit filed for Investors who lost money with shares of aTyr Pharma, Inc. (NASDAQ: ATYR) here
News-ID: 4243925 • Views: …
More Releases from Shareholders Foundation, Inc.
Lawsuit Alert: Investors who lost money with shares of WPP plc (NYSE: WPP) shoul …
An investor, who purchased shares of WPP plc (NYSE: WPP), filed a lawsuit in the U.S. over alleged violations of Federal Securities Laws by WPP plc (NYSE: WPP in connection with certain allegedly false and misleading statements made between February 27, 2025, to July 8, 2025.
Investors who purchased a significant amount of shares of WPP plc (NYSE: WPP) between February 27, 2025, to July 8, 2025, have certain options and…
Semler Scientific, Inc. (NASDAQ: SMLR) Investor Alert: Deadline in Lawsuit on Oc …
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Semler Scientific, Inc. (NASDAQ: SMLR) over alleged securities laws violations by Semler Scientific, Inc.
Investors who purchased shares of Semler Scientific, Inc. (NASDAQ: SMLR) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Semler Scientific, Inc. (NASDAQ: SMLR) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or…
Investigation announced for Investors who hold shares of Nutex Health Inc. (NASD …
An investigation was announced for current long-term investors in shares of Nutex Health Inc. (NASDAQ: NUTX) concerning potential breaches of fiduciary duties by certain directors of Nutex Health Inc.
Investors who are current long term investors in Nutex Health Inc. (NASDAQ: NUTX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors…
Lawsuit Alert: Investors who lost money with shares of Molina Healthcare, Inc. ( …
An investor, who purchased shares of Molina Healthcare, Inc. (NYSE: MOH), filed a lawsuit over alleged violations of Federal Securities Laws by Molina Healthcare, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Molina Healthcare, Inc. (NYSE: MOH) have certain options and for certain investors are short and strict deadlines running. Deadline: December 02, 2025. NYSE: MOH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
